Weiss Ratings Reaffirms “Sell (D+)” Rating for Guardian Pharmacy Services (NYSE:GRDN)

Guardian Pharmacy Services (NYSE:GRDN)‘s stock had its “sell (d+)” rating reissued by equities research analysts at Weiss Ratings in a research note issued on Wednesday,Weiss Ratings reports.

A number of other research analysts have also weighed in on the company. Truist Financial boosted their target price on Guardian Pharmacy Services from $28.00 to $30.00 and gave the stock a “buy” rating in a report on Friday, September 26th. Wall Street Zen lowered Guardian Pharmacy Services from a “strong-buy” rating to a “buy” rating in a report on Friday, October 3rd. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, Guardian Pharmacy Services currently has an average rating of “Moderate Buy” and an average target price of $26.33.

Guardian Pharmacy Services Trading Down 0.1%

GRDN stock opened at $23.71 on Wednesday. The firm has a market capitalization of $1.50 billion and a PE ratio of -15.60. Guardian Pharmacy Services has a 1-year low of $16.50 and a 1-year high of $30.39. The business’s 50 day simple moving average is $25.21 and its 200 day simple moving average is $23.08.

Institutional Trading of Guardian Pharmacy Services

Several institutional investors have recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. boosted its stake in Guardian Pharmacy Services by 7.1% in the 2nd quarter. Envestnet Asset Management Inc. now owns 12,126 shares of the company’s stock valued at $258,000 after purchasing an additional 805 shares during the period. GAMMA Investing LLC bought a new stake in Guardian Pharmacy Services in the 1st quarter valued at $170,000. Police & Firemen s Retirement System of New Jersey boosted its stake in Guardian Pharmacy Services by 76.8% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company’s stock valued at $52,000 after purchasing an additional 1,062 shares during the period. Allspring Global Investments Holdings LLC boosted its stake in Guardian Pharmacy Services by 0.5% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 285,885 shares of the company’s stock valued at $6,092,000 after purchasing an additional 1,338 shares during the period. Finally, Marshall Wace LLP boosted its stake in Guardian Pharmacy Services by 13.9% in the 2nd quarter. Marshall Wace LLP now owns 15,442 shares of the company’s stock valued at $329,000 after purchasing an additional 1,883 shares during the period.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.